Meeting
2024 ASCO Annual Meeting
Association of circulating T lymphocytes and their functional states with pathologic complete response (pCR) in breast cancer (BC). A prospective Italian study.
Authors
Rahma Ben Ayed
University of Eastern Piedmont, Novara, Novara, Italy
Rahma Ben Ayed , Benedetta Conte , Veronica Martini , Renzo Boldorini , Simone Gobbato , Beatrice Ruffilli , Francesca Vezzoli , Rami Alsati , Letizia Negrini , Nicole Sala , Letizia Matera , Carmen Branni , Ivan Dodaro , Anna Gambaro , Valentina Rossi , Francesca D'Avanzo , Alessandra Gennari
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 559)
DOI
10.1200/JCO.2024.42.16_suppl.559
Abstract #
559
Poster Bd #
151
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
A phase II trial to assess the impact of β2 adrenergic blockade in immune checkpoint inhibitor (ICI)– refractory metastatic triple negative breast cancer (mTNBC).
First Author: Shipra Gandhi
Poster
2021 Gastrointestinal Cancers Symposium
Margetuximab (M) combined with anti-PD-1 (retifanlimab) or anti-PD-1/LAG-3 (tebotelimab) +/- chemotherapy (CTX) in first-line therapy of advanced/metastatic HER2+ gastroesophageal junction (GEJ) or gastric cancer (GC).
First Author: Daniel V.T. Catenacci
Poster
2018 ASCO Annual Meeting
Immune profiling in a randomized phase II trial of acalabrutinib and pembrolizumab (PA) versus pembrolizumab (P) for patients with metastatic urothelial cancer (mUC).
First Author: Tian Zhang
Poster
2017 ASCO Annual Meeting
Changes in p16INK4a (p16) expression, a biomarker of aging, in peripheral blood T-cells (PBTC) in patients receiving anthracycline (A) vs non-anthracycline (NoA) chemotherapy (CRx) for early-stage breast cancer (EBC).
First Author: Shlomit Strulov Shachar